PENTOXIFYLLINE (Apotex Corp.)
Welcome to the PulseAid listing for the PENTOXIFYLLINE drug offered from Apotex Corp.. This Blood Viscosity Reducer [EPC],Hematologic Activity Alteration [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Apotex Corp. |
NON-PROPRIETARY NAME: | PENTOXIFYLLINE |
SUBSTANCE NAME: | PENTOXIFYLLINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Blood Viscosity Reducer [EPC],Hematologic Activity Alteration [PE] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, EXTENDED RELEASE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 1999-06-10 |
END MARKETING DATE: | 0000-00-00 |
PENTOXIFYLLINE HUMAN PRESCRIPTION DRUG Details:
Item Description | PENTOXIFYLLINE from Apotex Corp. |
LABELER NAME: | Apotex Corp. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 400(mg/1) |
START MARKETING DATE: | 1999-06-10 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 60505-0033_ae193845-6ab7-325b-d4f2-3f3fd8819553 |
PRODUCT NDC: | 60505-0033 |
APPLICATION NUMBER: | ANDA075191 |
Other PENTOXIFYLLINE Pharmaceutical Manufacturers / Labelers: